Keith C. Regnante
2017
In 2017, Keith C. Regnante earned a total compensation of $761.8K as Chief Financial Officer at Wave Life Sciences Ltd., a 54% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,100 |
|---|---|
| Option Awards | $159,296 |
| Salary | $327,400 |
| Stock Awards | $124,915 |
| Other | $6,136 |
| Total | $761,847 |
Regnante received $327.4K in salary, accounting for 43% of the total pay in 2017.
Regnante also received $144.1K in non-equity incentive plan, $159.3K in option awards, $124.9K in stock awards and $6.1K in other compensation.
Rankings
In 2017, Keith C. Regnante's compensation ranked 10,228th out of 14,666 executives tracked by ExecPay. In other words, Regnante earned more than 30.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,228 out of 14,666 | 30th |
Division Manufacturing | 3,962 out of 5,768 | 31st |
Major group Chemicals And Allied Products | 1,390 out of 2,074 | 33rd |
Industry group Drugs | 1,128 out of 1,730 | 35th |
Industry Pharmaceutical Preparations | 882 out of 1,329 | 34th |
Source: SEC filing on June 26, 2019.
Regnante's colleagues
We found four more compensation records of executives who worked with Keith C. Regnante at Wave Life Sciences Ltd. in 2017.
2017
Paul Bolno
Wave Life Sciences Ltd.
Chief Executive Officer
2017
Chandra Vargeese
Wave Life Sciences Ltd.
Senior Vice President, Drug Discovery
2017
Christopher Francis
Wave Life Sciences Ltd.
Senior Vice President, Corporate Development, Head of Emerging Areas
2017
Michael Panzara
Wave Life Sciences Ltd.